USPTO serial 87904724
EUROARRAY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 9, 2021
- Examiner
- AURAND, KYLE C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with EUROARRAY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,300
Owner
EUROIMMUN Medizinische Labordiagnostika AG
Lübeck, DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
Lübeck, DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG
Lübeck, DE
Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevan L. Morgan
Kevan L. Morgan SEED IP LAW GROUP LLP701 FIFTH AVENUESUITE 5400SEATTLE, WA 98104Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations, diagnostic agents and diagnostic substances for scientific purposes, in particular immobilized proteins, cells or viruses or components thereof, nucleic acid sequences, biomarker and biological tissue cultures on a carrier material in the nature of a biochip; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier | ACTIVE | — |
| 005 | Diagnostic agents, in particular diagnostic agents for medical and veterinary purposes; Diagnostic agents for medical and veterinary purposes; Diagnostic agents for medical and veterinary purposes, namely, immobilized proteins, cells or viruses or components thereof, nucleic acid sequences, biomarker and biological tissue cultures on a support material in the nature of a biochip; Reagents for medical and veterinary diagnostics; Reagents for medical and veterinary diagnostics, namely, immobilized proteins, cells or viruses or components thereof, nucleic acid sequences, biomarker and biological tissue cultures on a support material in the nature of a biochip; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier | ACTIVE | — |
| 009 | Measuring, detecting and monitoring devices, namely, medical laboratory research instruments for preparing, processing and evaluating diagnostic samples; Sensors and detectors, namely, medical laboratory research instruments for detecting UV fluorescence and chemiluminescence for preparing, processing and evaluating diagnostic samples; Apparatuses for recording, transmission and reproduction of diagnostic data, sound and images, namely, cameras, microscopes, photometers, microplate photometers, enzyme linked immunosorbent assay readers, photomultiplier, and microplate readers; Laboratory software for recording, transmitting and reproducing diagnostic data, sound and images; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier | ACTIVE | — |
| 010 | Medical apparatus and instruments for medical examinations and medical diagnosis, namely, sample preparation devices for medical diagnostic uses, in particular for determining neurological diseases, infectious diseases, autoimmune diseases, allergies and cancer; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks owned by EUROIMMUN Medizinische Labordiagnostika AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named EUROARRAY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 9, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 9, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 22, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 22, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 2, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 13, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 13, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 13, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 13, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 13, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 12, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 12, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 3, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 21, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Aug 21, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Aug 21, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 21, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 21, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 21, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 19, 2020 | ALIE | ASSIGNED TO LIE | — |
| Feb 13, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 14, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Aug 14, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Aug 14, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 11, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 11, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 11, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 9, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 8, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 8, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 13, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 13, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 11, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 5, 2018 | NWAP | NEW APPLICATION ENTERED | — |